What is the address of ECOMED Research?

The registered office of ECOMED Research is located at Louizalaan 367, 1050 Brussel.

Is ECOMED Research still active?

Yes. According to the CBE (18 September 2026) ECOMED Research is active, legal situation “Normale toestand”, started on 20 July 2020.

Is ECOMED Research registered on Peppol?

No, ECOMED Research is currently not registered on the Peppol network.

What is the enterprise number of ECOMED Research?

The enterprise number of ECOMED Research is BE0750848096.

When was ECOMED Research founded?

ECOMED Research was founded on 20 July 2020.

Who are the directors of ECOMED Research?

According to the 2024 annual accounts, the directors of ECOMED Research are: Geert Seynaeve.

Is ECOMED Research a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 July 2020; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did ECOMED Research make in 2024?

ECOMED Research posted a profit after taxes of € 4,946 in financial year 2024.

What is the revenue of ECOMED Research?

As a small company, ECOMED Research is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 5,871.

ECOMED Research (Private Limited) - Brussel

Dossier ECOMED Research, printed on 18 September 2026 from databakkes.be/en/0750848096/ecomed-research. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

ECOMED Research from Brussel, company number BE0750848096, closed financial year 2024 with a result of € 4,946 after tax. For that financial year ECOMED Research recorded a gross margin of € 5,871 and equity of € 3,692. Compared with financial year 2023, the result moved from € -799 to € 4,946. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.

What it is worth Growing

€ 3,692

▲ € 4,946 vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 4,946

▲ still € 799 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 8,715

▲ 103% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 3,349.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 387

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 71

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ -3,249 Gross margin 2021: € -3,249 First fiscal year in the series	€ 2,279 Gross margin 2022: € 2,279 ▲ € 5,528 vs 2021 (€ -3,249) Favourable step	€ 494 Gross margin 2023: € 494 ▼ 78% vs 2022 (€ 2,279) Unfavourable step	€ 5,871 Gross margin 2024: € 5,871 ▲ € 5,377 vs 2023 (€ 494) Favourable step	▲ € 5,377
Profit after taxes	€ -6,501 Profit after taxes 2021: € -6,501 First fiscal year in the series	€ 1,018 Profit after taxes 2022: € 1,018 ▲ € 7,519 vs 2021 (€ -6,501) Favourable step	€ -799 Profit after taxes 2023: € -799 ▼ € 1,817 vs 2022 (€ 1,018) Unfavourable step	€ 4,946 Profit after taxes 2024: € 4,946 ▲ € 5,745 vs 2023 (€ -799) Favourable step	▲ € 5,745
Equity	€ -1,473 Equity 2021: € -1,473 First fiscal year in the series	€ -455 Equity 2022: € -455 ▲ € 1,018 vs 2021 (€ -1,473) Favourable step	€ -1,254 Equity 2023: € -1,254 ▼ € 799 vs 2022 (€ -455) Unfavourable step	€ 3,692 Equity 2024: € 3,692 ▲ € 4,946 vs 2023 (€ -1,254) Favourable step	▲ € 4,946
Total debts	€ 7,144 Total debts 2021: € 7,144 First fiscal year in the series	€ 6,857 Total debts 2022: € 6,857 ▼ 4% vs 2021 (€ 7,144) Favourable step	€ 6,468 Total debts 2023: € 6,468 ▼ 6% vs 2022 (€ 6,857) Favourable step	€ 5,723 Total debts 2024: € 5,723 ▼ 12% vs 2023 (€ 6,468) Favourable step	▼ 12%
Cash	€ 2,643 Cash 2021: € 2,643 First fiscal year in the series	€ 4,628 Cash 2022: € 4,628 ▲ 75% vs 2021 (€ 2,643) Favourable step	€ 4,292 Cash 2023: € 4,292 ▼ 7% vs 2022 (€ 4,628) Unfavourable step	€ 8,715 Cash 2024: € 8,715 ▲ 103% vs 2023 (€ 4,292) Favourable step	▲ 103%
Retained profit	€ -1,817 Retained profit 2021: € -1,817 First fiscal year in the series	€ -799 Retained profit 2022: € -799 ▲ € 1,018 vs 2021 (€ -1,817) Favourable step	€ -1,598 Retained profit 2023: € -1,598 ▼ € 799 vs 2022 (€ -799) Unfavourable step	€ 3,349 Retained profit 2024: € 3,349 ▲ € 4,946 vs 2023 (€ -1,598) Favourable step	▲ € 4,946
Balance sheet total	€ 5,670 Balance sheet total 2021: € 5,670 First fiscal year in the series	€ 6,402 Balance sheet total 2022: € 6,402 ▲ 13% vs 2021 (€ 5,670) Unchanged	€ 5,214 Balance sheet total 2023: € 5,214 ▼ 19% vs 2022 (€ 6,402) Unchanged	€ 9,416 Balance sheet total 2024: € 9,416 ▲ 81% vs 2023 (€ 5,214) Unchanged	▲ 81%

Key figures of ECOMED Research, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to ECOMED Research?

What happened at ECOMED Research in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2025 New annual accounts for financial year 2024: profit of € 4,946. filed late Source: NBB ↗
Jul 20, 2020 New establishment in Schaarbeek. KBO
Jul 20, 2020 Start of the company according to the CBE. KBO

In short

From € 6,501 loss in 2021 to € 4,946 profit in 2024.

Paid € 71 in corporate taxes since 2021.

Best year ever: 2024, with € 4,946 profit.

Original PDFs at the National Bank ↗

A new publication or filing at ECOMED Research? We notify you, reason included.

Follow ECOMED Research

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit